Nicole Keith

Nicole Keith has extensive work experience in investor relations and finance roles. Nicole is currently the Vice President of Finance at Sana Biotechnology, where they lead a team responsible for financial planning and analysis, investor relations, and corporate communications. Prior to this, Nicole worked as the Senior Director of Investor Relations at Juno Therapeutics, where they developed and implemented the company's investor relations strategy and served as a spokesperson to the investment community. Nicole also held the position of Associate Director of Investor Relations at Gilead Sciences and Onyx Pharmaceuticals, where they played a key role in designing and implementing investor relations strategies. Nicole began their career at Genentech, where they held various roles, including Senior Manager of Investor Relations and Finance Manager in the CFO Rotation Program. Nicole also gained experience as a Summer MBA Intern at Biogen Idec. Nicole's background includes expertise in financial planning, shareholder communications, corporate branding, and strategic planning.

Nicole Keith completed their Bachelor of Science degree in Chemical Engineering at Stanford University from 1995 to 1999. Later, from 2003 to 2005, they pursued an MBA in Biotechnology at Northwestern University - Kellogg School of Management.